Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S2W-06234 · Session 2

Further to the answer to question S2W-5869 by Malcolm Chisholm on 10 February 2004, whether the increase of #305,986 between 2002 and 2003 …

Answered Asked by Adam Ingram SNP Lodged 12 Feb 2004

The question

To ask the Scottish Executive, further to the answer to question S2W-5869 by Malcolm Chisholm on 10 February 2004, whether the increase of #305,986 between 2002 and 2003 of the gross ingredient cost of methylphenidate hydrochloride was solely due to the introduction of Concerta XL; what the total cost of Concerta XL has been since its introduction, and how many prescriptions of Concerta XL have been issued.

The answer

Answered by Malcolm Chisholm on 16 Mar 2004 · 33 days after it was lodged, on time

The following table shows the number of prescribed items and gross ingredient cost for Concerta XL® and all other forms of methylphenidate hydrochloride (Ritalin®, Equasym®, Tranquilyn®) for the financial years ending 31 March 2002 and2003. No changes in pack prices occurred during that period therefore it would appear that the increase in costs is attributable to greater use of the modified release preparation Concerta XL®.


| No of prescribed items
| Gross ingredient cost £


| 2002
| 2003
| 2002
| 2003

Concerta XL®
| 46
| 7,507
| 2,723
| 359,358

All other forms of methylphenidate hydrochloride
| 24,840
| 22,769
| 477,819
| 427,170

Total
| 24,886
| 30,276
| 480,542
| 786,528


The cost given is thatbefore addition of any pharmacy fees and deduction of any discount and patientcharges. Data in the table refer to prescriptions dispensed by communitypharmacists and dispensing doctors, but do not take into account medicinesdispensed by hospitals or hospital based clinics.
The information in the tablehas been provided by ISD.

In the Official Report

No contribution in the Official Report cites S2W-06234 by reference.